The FDA recently announced a voluntary recall of a popular Sinu Cleanse nasal spray sold at retailers like H-E-B, Walgreens, ...
A nasal spray being developed to target brain inflammation can also prove effective in treating traumatic brain injury (TBI) ...
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to healthcare providers and a recall by one manufacturer, according to a January ...
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...
While the “winter blues” might stir mild feelings of sadness as the weather gets colder, SAD is characterized by a persistent depression that lasts at least two weeks. One of the greatest ...
Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with depression and suicidal thoughts- especially when anti-depressants and talk ...
The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression. Parkside Psychiatric Hospital has a Spravato outpatient ...
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
The Colton School District says damage was done to their youth fields last week after someone drove their car onto the fields in the snow. More than 1,000 protestors took to the streets in ...
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...
That's still possible but no longer required.) For treatment-resistant depression, patients usually get the esketamine nasal spray twice a week for one to four weeks. Then they take it once a week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results